176 related articles for article (PubMed ID: 2823400)
1. Cryolumpectomy for carcinoma of the breast.
Rand RW; Rand RP; Eggerding F; DenBesten L; King W
Surg Gynecol Obstet; 1987 Nov; 165(5):392-6. PubMed ID: 2823400
[TBL] [Abstract][Full Text] [Related]
2. Cryolumpectomy for breast cancer: an experimental study.
Rand RW; Rand RP; Eggerding FA; Field M; Denbesten L; King W; Camici S
Cryobiology; 1985 Aug; 22(4):307-18. PubMed ID: 2992882
[TBL] [Abstract][Full Text] [Related]
3. Experimental evaluation of in situ oncocide for primary tumor therapy: comparison of tumor-specific immunity after complete excision, cryonecrosis and ligation.
Neel HB; Ketcham AS; Hammond WG
Laryngoscope; 1973 Mar; 83(3):376-87. PubMed ID: 4690029
[No Abstract] [Full Text] [Related]
4. Pre-, peri-, and postoperative chemotherapy for breast cancer: is one better than the other?
Murthy MS; Scanlon EF; Reid SE; Yang XF
J Surg Oncol; 1996 Apr; 61(4):273-7. PubMed ID: 8627997
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of reduction of tumor recurrence with carbon dioxide laser in experimental mammary tumors.
Lanzafame RJ; McCormack CJ; Rogers DW; Naim JO; Herrera HR; Hinshaw JR
Surg Gynecol Obstet; 1988 Dec; 167(6):493-6. PubMed ID: 3142066
[TBL] [Abstract][Full Text] [Related]
6. Differences in progression of BALB/cfRIII and BALB/cfC3H mammary hyperplastic alveolar nodules transplanted into the gland-free fat pads of BALB/c mice.
Basolo F; Fontanini G; Squartini F
Cancer Res; 1988 Jun; 48(11):3197-202. PubMed ID: 2835155
[TBL] [Abstract][Full Text] [Related]
7. Margin status after breast-conserving treatment of breast cancer: how much free margin is enough?
von Smitten K
J Surg Oncol; 2008 Dec; 98(8):585-7. PubMed ID: 19072849
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ.
Fleming NI; Trivett MK; George J; Slavin JL; Murray WK; Moseley JM; Anderson RL; Thomas DM
Cancer Res; 2009 Sep; 69(18):7473-9. PubMed ID: 19723659
[TBL] [Abstract][Full Text] [Related]
9. [10 years' experience with the concept of breast-saving therapy in the treatment of breast cancer].
Staffen A; Stadler B; Strasser K; Schreiner W; Wolner E
Chirurg; 1985 Jul; 56(7):436-9. PubMed ID: 2994965
[TBL] [Abstract][Full Text] [Related]
10. [Bilateral carcinoma of the male breast. Analysis of a clinical case].
Giaume M; Calcina GG; Briglia R
Minerva Med; 1986 May; 77(22-23):989-93. PubMed ID: 3014382
[TBL] [Abstract][Full Text] [Related]
11. Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast.
Macdonald HR; Silverstein MJ; Lee LA; Ye W; Sanghavi P; Holmes DR; Silberman H; Lagios M
Am J Surg; 2006 Oct; 192(4):420-2. PubMed ID: 16978941
[TBL] [Abstract][Full Text] [Related]
12. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
[TBL] [Abstract][Full Text] [Related]
13. Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?
Solin LJ
J Clin Oncol; 2006 Mar; 24(7):1017-9. PubMed ID: 16461780
[No Abstract] [Full Text] [Related]
14. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
[TBL] [Abstract][Full Text] [Related]
15. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
Westenberg AH; Rutgers EJ; Peterse JL; Hendriks JH; Beex LV; van Tienhoven G
Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2157-61. PubMed ID: 14626831
[TBL] [Abstract][Full Text] [Related]
16. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tumor immunity after complete excision, cryonecrosis, and in the presence of persistent tumor.
Neel HB; Ketcham AS; Hammond WG
Surg Forum; 1970; 21():120-2. PubMed ID: 5514704
[No Abstract] [Full Text] [Related]
18. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).
Samant RS; Debies MT; Hurst DR; Moore BP; Shevde LA; Welch DR
Cancer Lett; 2006 Apr; 235(2):260-5. PubMed ID: 15978719
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
[TBL] [Abstract][Full Text] [Related]
20. Adoptive immunotherapy of breast cancer with lymph node cells primed by cryoablation of the primary tumor.
Sabel MS; Arora A; Su G; Chang AE
Cryobiology; 2006 Dec; 53(3):360-6. PubMed ID: 16973145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
